Jonathan Aschoff
Stock Analyst at Roth MKM
(0.03)
# 4,694
Out of 4,698 analysts
449
Total ratings
28.9%
Success rate
-21%
Average return
Main Sectors:
Stocks Rated by Jonathan Aschoff
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| APVO Aptevo Therapeutics | Maintained: Buy | $21 | $1.71 | +1,128.07% | 12 | Sep 3, 2026 | |
| CELZ Creative Medical Technology Holdings | Maintained: Buy | $20 | $1.06 | +1,786.79% | 9 | Aug 20, 2026 | |
| GTBP GT Biopharma | Maintained: Buy | $3 | $0.2524 | +1,088.59% | 6 | Aug 17, 2026 | |
| CLNN Clene | Maintained: Buy | $30 | $4.00 | +650.94% | 7 | Aug 17, 2026 | |
| MDCX Medicus Pharma | Maintained: Buy | $9 | $0.1705 | +5,178.59% | 4 | Aug 14, 2026 | |
| TENX Tenax Therapeutics | Maintained: Buy | $30 → $5 | $1.78 | +180.90% | 8 | Aug 10, 2026 | |
| REVB Revelation Biosciences | Maintained: Buy | $16 | $1.01 | +1,484.16% | 14 | Aug 7, 2026 | |
| ZVRA Zevra Therapeutics | Maintained: Buy | $21 | $12.54 | +67.46% | 18 | Aug 6, 2026 | |
| MBRX Moleculin Biotech | Maintained: Buy | $31 | $0.6755 | +4,489.19% | 17 | Aug 4, 2026 | |
| NVCT Nuvectis Pharma | Rated: Buy | $20 → $33 | $24.37 | +35.41% | 3 | Jul 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 | $0.5068 | +1,873.16% | 15 | May 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 | $1.51 | +496.03% | 12 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $55 | $24.36 | +125.78% | 5 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $14 → $11 | $2.35 | +368.09% | 10 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $18 → $15 | $0.1437 | +10,338.41% | 10 | Apr 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 → $3 | $0.0001 | n/a | 8 | Jul 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 → $2 | $0.015 | n/a | 11 | Jun 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $13 → $11 | $0.7347 | n/a | 5 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €12.00 | €2.81 | n/a | 5 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.9216 | n/a | 5 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $0.59 | $0.07 | n/a | 1 | Sep 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $36 | $2.97 | n/a | 9 | May 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $25 → $36 | $38.00 | n/a | 2 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $250 → $24 | $2.35 | n/a | 2 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $620 → $500 | $0.0001 | n/a | 3 | Dec 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 | $13.83 | n/a | 2 | Feb 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $8 | $1.35 | n/a | 1 | Jun 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 → $30 | $0.1831 | n/a | 3 | Apr 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 | $0.1687 | n/a | 5 | Oct 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $2.5 → $8 | $0.0001 | n/a | 5 | Sep 27, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7 | $0.00001 | n/a | 4 | Aug 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $38 | $7.03 | n/a | 1 | Mar 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $18 | $0.0001 | n/a | 3 | Nov 22, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $8 | $1.36 | n/a | 17 | Nov 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 → $11 | $3.30 | n/a | 3 | Oct 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $13 → $26 | $2.27 | n/a | 2 | Jul 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $0.8565 | n/a | 1 | Apr 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 | $0.001 | n/a | 8 | Sep 15, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $2.05 | n/a | 12 | Sep 13, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $55 | $0.33 | n/a | 17 | Sep 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $29 | $208.35 | n/a | 5 | Aug 19, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $92 | $128.00 | n/a | 14 | Aug 10, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 | $0.35 | n/a | 10 | Aug 10, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 → $16 | $39.37 | n/a | 11 | Aug 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $4 → $3 | $7.99 | n/a | 12 | Aug 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 | $56.71 | n/a | 21 | Aug 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 | $0.9833 | n/a | 12 | Aug 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 | $5.35 | n/a | 6 | Aug 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $26.60 | n/a | 16 | Aug 5, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 → $18 | $76.37 | n/a | 13 | Aug 4, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $0.000001 | n/a | 10 | Jul 6, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $489 | $843.47 | n/a | 18 | Mar 8, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $0.3832 | n/a | 4 | Nov 12, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 | $1.04 | n/a | 3 | Dec 8, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $66.43 | n/a | 3 | Oct 24, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $490.24 | n/a | 1 | Feb 26, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $1 | $1.56 | n/a | 1 | Jan 17, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $36.13 | n/a | 2 | Jun 29, 2012 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $13 → $11 | $110.76 | n/a | 2 | Apr 16, 2012 |
Aptevo Therapeutics
Sep 3, 2026
Maintained: Buy
Price Target: $21
Current: $1.71
Upside: +1,128.07%
Creative Medical Technology Holdings
Aug 20, 2026
Maintained: Buy
Price Target: $20
Current: $1.06
Upside: +1,786.79%
GT Biopharma
Aug 17, 2026
Maintained: Buy
Price Target: $3
Current: $0.2524
Upside: +1,088.59%
Clene
Aug 17, 2026
Maintained: Buy
Price Target: $30
Current: $4.00
Upside: +650.94%
Medicus Pharma
Aug 14, 2026
Maintained: Buy
Price Target: $9
Current: $0.1705
Upside: +5,178.59%
Tenax Therapeutics
Aug 10, 2026
Maintained: Buy
Price Target: $30 → $5
Current: $1.78
Upside: +180.90%
Revelation Biosciences
Aug 7, 2026
Maintained: Buy
Price Target: $16
Current: $1.01
Upside: +1,484.16%
Zevra Therapeutics
Aug 6, 2026
Maintained: Buy
Price Target: $21
Current: $12.54
Upside: +67.46%
Moleculin Biotech
Aug 4, 2026
Maintained: Buy
Price Target: $31
Current: $0.6755
Upside: +4,489.19%
Nuvectis Pharma
Jul 6, 2026
Rated: Buy
Price Target: $20 → $33
Current: $24.37
Upside: +35.41%
May 26, 2026
Maintained: Buy
Price Target: $10
Current: $0.5068
Upside: +1,873.16%
May 15, 2026
Maintained: Buy
Price Target: $9
Current: $1.51
Upside: +496.03%
May 15, 2026
Maintained: Buy
Price Target: $55
Current: $24.36
Upside: +125.78%
May 5, 2026
Rated: Buy
Price Target: $14 → $11
Current: $2.35
Upside: +368.09%
Apr 2, 2026
Maintained: Buy
Price Target: $18 → $15
Current: $0.1437
Upside: +10,338.41%
Jul 8, 2025
Maintained: Buy
Price Target: $4 → $3
Current: $0.0001
Upside: n/a
Jun 4, 2025
Maintained: Buy
Price Target: $9 → $2
Current: $0.015
Upside: n/a
May 13, 2025
Maintained: Buy
Price Target: $13 → $11
Current: $0.7347
Upside: n/a
May 12, 2025
Maintained: Buy
Price Target: €12.00
Current: €2.81
Upside: n/a
Oct 23, 2024
Downgraded: Hold
Price Target: n/a
Current: $0.9216
Upside: n/a
Sep 3, 2024
Maintained: Buy
Price Target: $0.59
Current: $0.07
Upside: n/a
May 21, 2024
Rated: Buy
Price Target: $36
Current: $2.97
Upside: n/a
Mar 7, 2024
Maintained: Buy
Price Target: $25 → $36
Current: $38.00
Upside: n/a
Mar 5, 2024
Maintained: Buy
Price Target: $250 → $24
Current: $2.35
Upside: n/a
Dec 18, 2023
Maintained: Buy
Price Target: $620 → $500
Current: $0.0001
Upside: n/a
Feb 27, 2023
Maintained: Buy
Price Target: $14
Current: $13.83
Upside: n/a
Jun 15, 2022
Initiated Coverage: Buy
Price Target: $8
Current: $1.35
Upside: n/a
Apr 28, 2022
Maintained: Buy
Price Target: $4 → $30
Current: $0.1831
Upside: n/a
Oct 25, 2021
Reiterated: Buy
Price Target: $24
Current: $0.1687
Upside: n/a
Sep 27, 2021
Upgraded: Buy
Price Target: $2.5 → $8
Current: $0.0001
Upside: n/a
Aug 30, 2021
Maintained: Buy
Price Target: $7
Current: $0.00001
Upside: n/a
Mar 11, 2021
Initiated Coverage: Buy
Price Target: $38
Current: $7.03
Upside: n/a
Nov 22, 2020
Maintained: Buy
Price Target: $18
Current: $0.0001
Upside: n/a
Nov 17, 2020
Downgraded: Sell
Price Target: $8
Current: $1.36
Upside: n/a
Oct 14, 2020
Reiterated: Buy
Price Target: $14 → $11
Current: $3.30
Upside: n/a
Jul 14, 2020
Maintained: Buy
Price Target: $13 → $26
Current: $2.27
Upside: n/a
Apr 20, 2020
Reiterated: Buy
Price Target: $9
Current: $0.8565
Upside: n/a
Sep 15, 2016
Reiterated: Buy
Price Target: $14
Current: $0.001
Upside: n/a
Sep 13, 2016
Reiterated: Buy
Price Target: $4
Current: $2.05
Upside: n/a
Sep 9, 2016
Reiterated: Buy
Price Target: $55
Current: $0.33
Upside: n/a
Aug 19, 2016
Reiterated: Buy
Price Target: $29
Current: $208.35
Upside: n/a
Aug 10, 2016
Reiterated: Buy
Price Target: $92
Current: $128.00
Upside: n/a
Aug 10, 2016
Reiterated: Buy
Price Target: $24
Current: $0.35
Upside: n/a
Aug 9, 2016
Reiterated: Buy
Price Target: $24 → $16
Current: $39.37
Upside: n/a
Aug 9, 2016
Reiterated: Sell
Price Target: $4 → $3
Current: $7.99
Upside: n/a
Aug 9, 2016
Reiterated: Buy
Price Target: $28
Current: $56.71
Upside: n/a
Aug 9, 2016
Reiterated: Buy
Price Target: $26
Current: $0.9833
Upside: n/a
Aug 9, 2016
Reiterated: Buy
Price Target: $16
Current: $5.35
Upside: n/a
Aug 5, 2016
Reiterated: Hold
Price Target: n/a
Current: $26.60
Upside: n/a
Aug 4, 2016
Reiterated: Buy
Price Target: $16 → $18
Current: $76.37
Upside: n/a
Jul 6, 2016
Reiterated: Buy
Price Target: $8
Current: $0.000001
Upside: n/a
Mar 8, 2016
Initiated Coverage: Buy
Price Target: $489
Current: $843.47
Upside: n/a
Nov 12, 2015
Reiterated: Buy
Price Target: $5
Current: $0.3832
Upside: n/a
Dec 8, 2014
Maintained: Buy
Price Target: $16
Current: $1.04
Upside: n/a
Oct 24, 2014
Maintained: Hold
Price Target: n/a
Current: $66.43
Upside: n/a
Feb 26, 2013
Downgraded: Hold
Price Target: n/a
Current: $490.24
Upside: n/a
Jan 17, 2013
Downgraded: Sell
Price Target: $1
Current: $1.56
Upside: n/a
Jun 29, 2012
Reiterated: Buy
Price Target: n/a
Current: $36.13
Upside: n/a
Apr 16, 2012
Maintained: Buy
Price Target: $13 → $11
Current: $110.76
Upside: n/a